trending Market Intelligence /marketintelligence/en/news-insights/trending/cFrBxVZQhw1-hU0Bo-gANg2 content esgSubNav
In This List

Sisram Medical offering underwriters exercise overallotment option

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Sisram Medical offering underwriters exercise overallotment option

Underwriters in Sisram Medical Ltd.'s global offering exercised their option to buy an additional 2,155,600 shares at HK$8.88 apiece, raising about HK$18.3 million in additional net proceeds.

Following the underwriters' partial exercise of their overallotment option, the indirect interest of Sisram Medical's parent companies, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. and Fosun International Ltd., decreased to about 52.70% from about 52.96%.